# Differential Effectiveness of Aromatase Inhibitors in Hormone Receptor–Positive Breast Cancer

**Authors:** Laura C. Pinheiro, Shoshana M. Rosenberg

PMC · DOI: 10.1001/jamanetworkopen.2025.51548 · JAMA network open · 2026-02-10

## Full-text entities

- **Genes:** CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}
- **Diseases:** Breast Cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12888843/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12888843/full.md

---
Source: https://tomesphere.com/paper/PMC12888843